Faculties

Anchorperson: Thomas Modine ​
Spokesperson: Ralph Stephan von Bardeleben ​
Discussants: Ole De Backer, Alison Duncan, Nicolas Van Mieghem, Hendrik Treede

Learning objectives

Join us if you want

  • To gain insights on the APOLLO TMVR trial
  • To better understand the treatment goals of mitral regurgitation elimination
  • To learn about early APOLLO EU trial experience and the Intrepid 29Fr TMVR system

Agenda

Time Intervention title Faculty
13:45 Welcome and session objectives Thomas Modine
13:47 Benefits of mitral regurgitation elimination and the potential of TMVR Hendrik Treede
13:57 Intrepid TMVR trial status and transitioning to the 29Fr system Ralph Stephan Von Bardeleben
14:07

Case Review 1: 29Fr mitral regurgitation

 Thomas Modine
14:15

Discussion and audience interaction

All panelists
14:20 Patient screening for Intrepid TMVR and navigating mitral annular calcification Nicolas Van Mieghem
14:30

Case Review 2: 29Fr in mitral annular calcification

 TBD
14:38

Discussion and audience interaction

All panelists
14:43 Session evaluation and key learnings Thomas Modine
Back home